Samer S Najjar

Summary

Country: USA

Publications

  1. doi request reprint An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial
    Samer S Najjar
    Departments of Internal Medicine and Cardiac Surgery, Medstar Heart Institute, Washington, DC Electronic address
    J Heart Lung Transplant 33:23-34. 2014
  2. pmc Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial
    Samer S Najjar
    Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
    JAMA 305:1863-72. 2011

Detail Information

Publications2

  1. doi request reprint An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial
    Samer S Najjar
    Departments of Internal Medicine and Cardiac Surgery, Medstar Heart Institute, Washington, DC Electronic address
    J Heart Lung Transplant 33:23-34. 2014
    ..In this study, we analyze the incidence of pump thrombus, evaluate the comparative effectiveness of various treatment strategies, and examine factors pre-disposing to the development of pump thrombus...
  2. pmc Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial
    Samer S Najjar
    Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
    JAMA 305:1863-72. 2011
    ..Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and improves left ventricular (LV) function...